Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Technologies Motivate Merger


MADISON, NJ--Last week's announced merger plans between American Home Products (AHP) here and Monsanto could be a signal that the powerful research and development technologies enabled by bio informatics and genomics are poised to transform the business landscape of the field of biotechnology.

The deal, valued at more than $34 billion, would create a company with operations in pharmaceuticals, agriculture, animal health, consumer healthcare, and nutrition with an estimated research budget of $3 billion.

In an interview with CNBC ( the companies' chairmen said that the revolution in biological sciences and genetics is driving the merger. An industry insider pointed out that a shorter time-to-market cycle for crop biotechnology products is one reason pharmaceutical companies are now transferring their genomic technologies to agriculture.

But another observer said that while the advantage of pooled bioinformatics and genomics capabilities "was clearly a major driver" of this merger, neither company has developed large bioinformatics of software shops in-house. "Monsanto has its agreement with Millennium, but internally both companies' bioinformatics expertise has been rather adhoc," he said.

Analysts predicted the move will enhance the combined companies' chance to take the lead in the race to find gene targets for agricultural and pharmaceutical products. The new company could also position itself as the world's largest agricultural products company.

Filed under

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.